Infection, Inflammation, and Atherosclerosis
2003; Lippincott Williams & Wilkins; Volume: 34; Issue: 2 Linguagem: Inglês
10.1161/01.str.0000054049.65350.ea
ISSN1524-4628
AutoresJ. David Spence, John W. Norris,
Tópico(s)Lipoproteins and Cardiovascular Health
ResumoHomeStrokeVol. 34, No. 2Infection, Inflammation, and Atherosclerosis Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBInfection, Inflammation, and Atherosclerosis J. David Spence and John Norris J. David SpenceJ. David Spence From the Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, London, Ontario (J.D.S.), and Stroke Research Unit, Sunnybrook & Women's College Hospital, University of Toronto, Toronto (J.N.), Canada. and John NorrisJohn Norris From the Stroke Prevention & Atherosclerosis Research Centre, Robarts Research Institute, London, Ontario (J.D.S.), and Stroke Research Unit, Sunnybrook & Women's College Hospital, University of Toronto, Toronto (J.N.), Canada. Originally published1 Feb 2003https://doi.org/10.1161/01.STR.0000054049.65350.EAStroke. 2003;34:333–334Only half of coronary artery disease,1,2 and half of carotid plaque measured by ultrasound,3 can be explained by the usual risk factors: age, sex, hypertension, hyperlipidemia, smoking, and diabetes. It is likely that much of unexplained atherosclerosis is genetic: a Swedish twin study showed that myocardial infarction below age 46 is almost entirely heritable.4 This suggests that few environmental factors remain to be discovered that would make a major contribution to atherosclerosis. Recently, the notion that infection may be important in atherosclerosis has been of interest.A recent study has shown that C-reactive protein, a marker of inflammation, was a stronger predictor of cardiovascular events than was low-density lipoprotein cholesterol level.5 It has been postulated for more than a century that infection may be responsible for atherosclerosis;6 this issue has recently been reviewed by Fong.7 Organisms that have been implicated include Chlamydia pneumoniae, cytomegalovirus, Helicobacter pylori, and periodontal infections.The mechanisms by which the association may be explained include increased coagulation,8,9 endothelial dysfunction,10 instability of plaque,11,12 and increased progression of atherosclerosis because of the influence of inflammation on plaque progression.13 In a rabbit model, infection accelerates atherosclerosis, and treatment with azithromycin prevents the effect.13Growing evidence suggests that infection with C pneumoniae may be associated with increased risk of coronary events14–16 and more rapid restenosis after angioplasty.17C pneumoniae has been identified in carotid endarterectomy specimens,18 and two studies have shown an association of Chlamydia antibody titers with stroke.19,20 Early studies of antibiotic treatment for C pneumoniae have shown mixed results.21–23Evidence that C pneumoniae infection is associated with antigenic mimicry of a heart muscle-specific protein24 has led to the hypothesis that perivascular inflammation around coronary arteries, caused by immune responses that have been misdirected against myocardial proteins, may explain the association of coronary artery disease and Chlamydia infection. This mechanism has been demonstrated in a rabbit model.25 If this is the case, Chlamydia infection may not predispose to carotid atherosclerosis or stroke.Recently, Chiu et al12,18 have found evidence of multiple infections, including agents associated with periodontal infection (P gingivalis and S sanguis), in carotid endarterectomy specimens. In one study of 76 carotid endarterectomy specimens, they detected C pneumoniae in 71%, cytomegalovirus in 35.5%, and herpes simplex virus in 10.5% of specimens, versus none of 20 normal control carotid and aortic specimens obtained at autopsy. At least one organism was detected in 77.6% of the specimens, with a single organism present in only 46%; two organisms were present in 23.7% and all three in 7.9%. Plaques with thrombosis were more likely to have C pneumoniae (80.4%) or cytomegalovirus (57.8%) than were plaques without thrombosis (56.7% and 16.7%, respectively). Chiu12 found that organisms were localized in plaque shoulders and adjacent to apoptotic areas and were associated with plaque ulceration and thrombosis.Singh et al26 recently found that a virulent strain of H pylori was associated with coronary events in the West of Scotland study cohort. Farsak et al27 found H pylori DNA in 37% of human endarterectomy specimens, but two other studies failed to find this organism in vascular tissues.28,29Some of the relationship between infection and vascular disease may be genetic. Mannose binding lectin,30 a protein involved in immune defenses against infections including Chlamydia species,31–33 may be more common among patients with unexplained atherosclerosis.34 Hegele et al35 have shown that this polymorphism is associated with carotid plaque.The strongest evidence for an association between infectious agents and cardiovascular disease is for C pneumoniae.7 Among more than 30 cross-sectional and retrospective studies, most show an association;36 however, a recent meta-analysis of 15 prospective studies found no significant association.37In a condition with so many risk factors and genetic influences,38 it seems unlikely that infection will be the only or main cause of atherosclerosis and events. The role of these newly emerging risk factors or markers (such as C-reactive protein), and their relationship with "traditional" risk factors such as hypertension or lipids, remains unexplored. The uncertainty of their role and the types of infection or types of patients that should be treated must be explored in properly conducted, prospective studies39 However, the findings to date are intriguing, and the hope that anti-infective therapy may reduce the burden of stroke is worth pursuing.The opinions expressed in this editorial are not necessarily those of the editors or of the American Stroke Association.FootnotesCorrespondence to David Spence, MD, Stroke Prevention & Atherosclerosis Research Centre, 1400 Western Rd, London, Ontario N6G 2V2, Canada. E-mail [email protected] References 1 Futterman LG, Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care. 1998; 7: 240–244.CrossrefMedlineGoogle Scholar2 Gordon T, Garcia-Palmieri MR, Kagan A, Kannel WB, Schiffman J. Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico. J Chron Dis. 1974; 27: 329–344.CrossrefMedlineGoogle Scholar3 Spence JD, Barnett PA, Bulman DE, Hegele RA. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis. Atherosclerosis. 1999; 144: 429–434.CrossrefMedlineGoogle Scholar4 Marenberg ME, Risch N, Berkman LF, Floderus B, de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 1994; 330: 1041–1046.CrossrefMedlineGoogle Scholar5 Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002; 347: 1557–1565.CrossrefMedlineGoogle Scholar6 Nieto FJ. Infections and atherosclerosis: new clues from an old hypothesis? Am J Epidemiol. 1998; 148: 937–948.CrossrefMedlineGoogle Scholar7 Fong IW. Infections and their role in atherosclerotic vascular disease. J Am Dent Assoc. 2002; 133 (suppl): 7S–13S.CrossrefMedlineGoogle Scholar8 Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield TC, Mendall MA. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet. 1994; 343: 1634–1635.CrossrefMedlineGoogle Scholar9 Fong IW. Emerging relations between infectious diseases and coronary artery disease and atherosclerosis. CMAJ. 2000; 163: 49–56.MedlineGoogle Scholar10 Vallance P, Collier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997; 349: 1391–1392.CrossrefMedlineGoogle Scholar11 Gurfinkel E, Bozovich G. Chlamydia pneumoniae: inflammation and instability of the atherosclerotic plaque. Atherosclerosis. 1998; 140 (suppl 1): S31–S35.CrossrefMedlineGoogle Scholar12 Chiu B. Multiple infections in carotid atherosclerotic plaques. Am Heart J. 1999; 138 (5 Pt 2): S534–S536.CrossrefMedlineGoogle Scholar13 Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, Carlquist JF. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998; 97: 633–636.CrossrefMedlineGoogle Scholar14 Campbell LA, Kuo CC, Grayston JT. Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis. 1998; 4: 571–579.CrossrefMedlineGoogle Scholar15 Saikku P. Chlamydia pneumoniae and atherosclerosis: an update. Scand J Infect Dis. 1997; 104 (suppl): 53–56.Google Scholar16 Shafran SD, Conly JM. Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides? Can J Cardiol. 1997; 13: 1017–1019.MedlineGoogle Scholar17 Carlsson J, Miketic S, Mueller KH, Brom J, Ross R, von Essen R, Tebbe U. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty. Lancet. 1997; 351: 1225.Google Scholar18 Chiu B, Viira E, Tucker W, Fong IW. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 1997; 96: 2144–2148.CrossrefMedlineGoogle Scholar19 Cook PJ, Honeybourne D, Lip GY, Beevers DG, Wise R, Davies P. Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project. Stroke. 1998; 29: 404–410.CrossrefMedlineGoogle Scholar20 Wimmer ML, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke. 1996; 27: 2207–2210.CrossrefMedlineGoogle Scholar21 Muhlestein JB, Anderson JL, Carlquist JF, Salunkhe K, Horne BD, Pearson RR, Bunch TJ, Allen A, Trehan S, Nielson C. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study. Circulation. 2000; 102: 1755–1760.CrossrefMedlineGoogle Scholar22 Gurfinkel E, Bozovich G, Beck E, Testa E, Livellara B, Mautner B. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes: the final report of the ROXIS Study. Eur Heart J. 1999; 20: 121–127.CrossrefMedlineGoogle Scholar23 Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997; 96: 404–407.CrossrefMedlineGoogle Scholar24 Bachmaier K, Neu N, de la Maza LM, Pal S, Hessel A, Penninger JM. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 1999; 283: 1335–1339.CrossrefMedlineGoogle Scholar25 Fong IW, Chiu B, Viira E, Fong MW, Jang D, Mahony J. Rabbit model for Chlamydia pneumoniae infection. J Clin Microbiol. 1997; 35: 48–52.CrossrefMedlineGoogle Scholar26 Singh RK, McMahon AD, Patel H, Packard CJ, Rathbone BJ, Samani NJ. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart. 2002; 88: 43–46.CrossrefMedlineGoogle Scholar27 Farsak B, Yildirir A, Akyon Y, Pinar A, Oc M, Boke E, Kes S, Tokgozoglu L. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol. 2000; 38: 4408–4411.CrossrefMedlineGoogle Scholar28 Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R, Rinaldi A, Fagetti L, Esposito G, Ruberti U, Allegra L. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996; 34: 2766–2769.CrossrefMedlineGoogle Scholar29 Danesh J, Koreth J, Youngman L, Collins R, Arnold JR, Balarajan Y, McGee J, Roskell D. Is Helicobacter pylori a factor in coronary atherosclerosis? J Clin Microbiol. 1999; 37: 1651.MedlineGoogle Scholar30 Ezekowitz RA. Genetic heterogeneity of mannose-binding proteins: the Jekyll and Hyde of innate immunity? Am J Hum Genet. 1998; 62: 6–9.CrossrefMedlineGoogle Scholar31 Turner MW. Mannose-binding lectin (MBL) in health and disease. Immunobiology. 1998; 199: 327–339.CrossrefMedlineGoogle Scholar32 Hibberd ML, Sumiya M, Summerfield JA, Booy R, Levin M. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease: Meningococcal Research Group. Lancet. 1999; 353: 1049–1053.CrossrefMedlineGoogle Scholar33 Swanson AF, Ezekowitz RA, Lee A, Kuo CC. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect Immun. 1998; 66: 1607–1612.CrossrefMedlineGoogle Scholar34 Madsen HO, Videm V, Svejgaard A, Svennevig JL, Garred P. Association of mannose-binding-lectin deficiency with severe atherosclerosis. Lancet. 1998; 352: 959–960.CrossrefMedlineGoogle Scholar35 Hegele RA, Ban MR, Anderson CM, Spence JD. Infection-susceptibility alleles of mannose-binding lectin are associated with increased carotid plaque area. J Investig Med. 2000; 48: 198–202.MedlineGoogle Scholar36 Grayston JT. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis. 2000; 181 (suppl 3): S402–S410.CrossrefMedlineGoogle Scholar37 Danesh J, Whincup P, Lewington S, Walker M, Lennon L, Thomson A, Wong YK, Zhou X, Ward M. Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis. Eur Heart J. 2002; 23: 371–375.CrossrefMedlineGoogle Scholar38 Hegele RA. The pathogenesis of atherosclerosis. Clin Chim Acta. 1996; 246: 21–38.CrossrefMedlineGoogle Scholar39 Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke. 2002; 33: 862–875.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Cheng J, Cai N, Jia T, Nian X, Kang S, Yang X and Li J (2011) Notice of Retraction: Relationship among MBL Gene Haplotypes, Genotype and Plasma Levels and Ischemic Cerebrovascular Disease 2011 5th International Conference on Bioinformatics and Biomedical Engineering, 10.1109/icbbe.2011.5780424, 978-1-4244-5088-6, (1-4) Ionita C, Siddiqui A, Levy E, Hopkins L, Snyder K and Gibbons K (2011) Acute Ischemic Stroke and Infections, Journal of Stroke and Cerebrovascular Diseases, 10.1016/j.jstrokecerebrovasdis.2009.09.011, 20:1, (1-9), Online publication date: 1-Jan-2011. Spence J and Rundek T (2011) Toward Clinical Applications of Carotid Ultrasound: Intima-Media Thickness, Plaque Area, and Three-Dimensional Phenotypes Ultrasound and Carotid Bifurcation Atherosclerosis, 10.1007/978-1-84882-688-5_25, (431-448), . Steinhoff M, Groves R, LeBoit P and Luger T (2010) Inflammation Rook's Textbook of Dermatology, 10.1002/9781444317633.ch12, (1-76) Wang Q, Zhou X and Huang D (2009) Role for Porphyromonas gingivalis in the progression of atherosclerosis, Medical Hypotheses, 10.1016/j.mehy.2008.04.030, 72:1, (71-73), Online publication date: 1-Jan-2009. Rizzo M, Corrado E, Coppola G, Muratori I, Novo G and Novo S (2008) Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol, Atherosclerosis, 10.1016/j.atherosclerosis.2007.12.020, 200:2, (389-395), Online publication date: 1-Oct-2008. Brocq M, Leslie S, Milliken P and Megson I (2008) Endothelial Dysfunction: From Molecular Mechanisms to Measurement, Clinical Implications, and Therapeutic Opportunities, Antioxidants & Redox Signaling, 10.1089/ars.2007.2013, 10:9, (1631-1674), Online publication date: 1-Sep-2008. Rizzo M, Corrado E, Coppola G, Muratori I and Novo S (2023) Prediction of Cerebrovascular and Cardiovascular Events in Patients with Subclinical Carotid Atherosclerosis, Journal of Investigative Medicine, 10.2310/jim.0b013e31816204ab, 56:1, (32-40), Online publication date: 1-Jan-2008. Gorelick P (2008) Chapter 63 The future of stroke prevention by risk factor modification Stroke Part III: Investigation and Management, 10.1016/S0072-9752(08)94063-X, (1261-1276), . Yoshikawa H, Aida K, Mori A, Muto S and Fukuda T (2007) Involvement of Helicobacter pylori Infection and Impaired Glucose Metabolism in the Increase of Brachial?Ankle Pulse Wave Velocity, Helicobacter, 10.1111/j.1523-5378.2007.00523.x, 12:5, (559-566), Online publication date: 1-Oct-2007. Walsh M, Shaffer L, Guikema B, Body S, Shernan S, Fox A, Collard C, Fung M, Taylor R and Stahl G (2007) Fluorochrome-linked immunoassay for functional analysis of the mannose binding lectin complement pathway to the level of C3 cleavage, Journal of Immunological Methods, 10.1016/j.jim.2007.04.004, 323:2, (147-159), Online publication date: 1-Jun-2007. Gibson F, Yumoto H, Takahashi Y, Chou H and Genco C (2016) Innate Immune Signaling and Porphyromonas gingivalis -accelerated Atherosclerosis , Journal of Dental Research, 10.1177/154405910608500202, 85:2, (106-121), Online publication date: 1-Feb-2006. Corrado E, Rizzo M, Tantillo R, Muratori I, Bonura F, Vitale G and Novo S (2005) Markers of Inflammation and Infection Influence the Outcome of Patients With Baseline Asymptomatic Carotid Lesions, Stroke, 37:2, (482-486), Online publication date: 1-Feb-2006. Bouwman J, Visseren F, Bevers L, van der Vlist W, Bouter K and Diepersloot R (2005) Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells, European Journal of Clinical Investigation, 10.1111/j.1365-2362.2005.01541.x, 35:9, (573-582), Online publication date: 1-Sep-2005. Harats D and George J (2014) Antigen-tailored therapy based on the inflammatory theory of atherosclerosis, Expert Review of Vaccines, 10.1586/14760584.3.5.605, 3:5, (605-611), Online publication date: 1-Oct-2004. Limas C, Iakovis P, Anyfantakis A, Kroupis C and Cokkinos D (2004) Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy, The American Journal of Cardiology, 10.1016/j.amjcard.2004.01.060, 93:9, (1189-1191), Online publication date: 1-May-2004. Mouta C and Heroult M (2003) Inflammatory Triggers of Lymphangiogenesis, Lymphatic Research and Biology, 10.1089/153968503768330247, 1:3, (201-218), Online publication date: 1-Jun-2003. February 2003Vol 34, Issue 2 Advertisement Article InformationMetrics https://doi.org/10.1161/01.STR.0000054049.65350.EAPMID: 12574527 Manuscript receivedNovember 29, 2002Manuscript acceptedDecember 13, 2002Originally publishedFebruary 1, 2003 KeywordsinflammationHelicobacter pyloriatherosclerosisChlamydia pneumoniaePDF download Advertisement
Referência(s)